» Authors » Seenu M Hariprasad

Seenu M Hariprasad

Explore the profile of Seenu M Hariprasad including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 161
Citations 1323
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hariprasad S, Holz F, Asche C, Issa A, Mora O, Keady S, et al.
Ophthalmol Ther . 2025 Feb; PMID: 40009268
Retinal diseases, such as neovascular age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion, pose a significant global burden on individuals, families, and healthcare systems. Intravitreal anti-vascular endothelial growth factor...
2.
3.
Wykoff C, Kuppermann B, Regillo C, Chang M, Hariprasad S, Duker J, et al.
J Vitreoretin Dis . 2024 Sep; 8(5):577-586. PMID: 39318989
To review sustained-release intraocular platforms used to treat diseases of the retina and choroid. A literature review of the current applications of biomaterials for sustained-release therapy in retinal and choroidal...
4.
Fashina T, Hariprasad S, Yeh S
Ophthalmic Surg Lasers Imaging Retina . 2024 Jul; 55(7):368-373. PMID: 39012195
No abstract available.
5.
Moir J, Hyman M, Gonnah R, Flores A, Hariprasad S, Skondra D
Invest Ophthalmol Vis Sci . 2024 Mar; 65(3):23. PMID: 38497512
Purpose: Metformin has been suggested to protect against the development of age-related macular degeneration (AMD) in multiple observational studies. However, the association between metformin and geographic atrophy (GA), a debilitating...
6.
Tan C, Hariprasad S, Sadda S
Ophthalmic Surg Lasers Imaging Retina . 2023 Dec; 54(12):682-685. PMID: 38113362
No abstract available.
7.
Aggarwal S, Moir J, Hyman M, Kaufmann G, Flores A, Hariprasad S, et al.
JAMA Ophthalmol . 2023 Nov; 142(1):53-57. PMID: 38019527
Importance: Metformin use may protect against the development of age-related macular degeneration (AMD) based on results from observational studies. However, its potential effectiveness among patients without diabetes remains unclear. Objective:...
8.
Ong J, Hariprasad S, Chhablani J
Ophthalmic Surg Lasers Imaging Retina . 2023 Oct; 54(10):557-562. PMID: 37847163
No abstract available.
9.
Chiang T, Kurup S, Hariprasad S
Ophthalmic Surg Lasers Imaging Retina . 2023 Aug; 54(8):440-445. PMID: 37603784
No abstract available.
10.
Tadayoni R, Jaffe G, Holz F, Schmidt-Erfurth U, Takahashi K, Cheung C, et al.
Ophthalmol Ther . 2023 Jun; 12(4):2209-2216. PMID: 37294524
Introduction: The HAWK and HARRIER studies evaluated the efficacy and safety of brolucizumab versus aflibercept in treatment-naïve eyes with neovascular age-related macular degeneration. Based on the study design, brolucizumab-treated eyes...